Evidence map›Paper›PMID 33317120›Full record

ArticleMolecules (Basel, Switzerland)2020

New Insights for Red Propolis of Alagoas-Chemical Constituents, Topical Membrane Formulations and Their Physicochemical and Biological Properties.

Valdemir C Silva, Abiane M G S Silva, Jacqueline A D Basílio, Jadriane A Xavier, Ticiano G do Nascimento, Rose M Z G Naal, Maria Perpetua Del Lama, Laila A D Leonelo, Naianny L O N Mergulhão, Fernanda C A Maranhão and 6 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nanomaterials in Skin Regeneration and Rejuvenation.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Valdemir C SilvaLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0002-2069-2812
Abiane M G S SilvaLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.
Jacqueline A D BasílioInstitute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Alagoas 57072-970, Brazil.
Jadriane A XavierInstitute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0002-2878-5589
Ticiano G do NascimentoLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0002-3856-8764
Rose M Z G NaalDepartment of BioMolecular Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto. Avenida do Café, s/n, Ribeirão Preto, São Paulo 14040-903, Brazil.
Maria Perpetua Del LamaDepartment of BioMolecular Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto. Avenida do Café, s/n, Ribeirão Preto, São Paulo 14040-903, Brazil.
Laila A D LeoneloDepartment of BioMolecular Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto. Avenida do Café, s/n, Ribeirão Preto, São Paulo 14040-903, Brazil.
Naianny L O N MergulhãoLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.
Fernanda C A MaranhãoInstitute of Biological Science and Health, Federal University of Alagoas, Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0002-4255-6563
Denise M W SilvaInstitute of Biological Science and Health, Federal University of Alagoas, Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0001-9641-4264
Robert OwenDivision of Preventive Oncology, German Cancer Research Center, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.ORCID 0000-0001-8264-2207
Ilza F B DuarteLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0003-0299-1007
Laisa C G BulhõesLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.
Irinaldo D BasílioLaboratory of Pharmaceutical Technology, Research Program Post-Graduation in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas 57072-970, Brazil.
Marília O F GoulartInstitute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Alagoas 57072-970, Brazil.ORCID 0000-0001-9860-3667
Universidade Federal de Alagoas · BRGerman Cancer Research Center · DE

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 435704/2018-4Conselho Nacional de Desenvolvimento Científico e Tecnológico INCT-BioanalíticaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior PROAP/RENORBIO
6 · The paper itself

Abstract

The main objectives of this study were to evaluate the chemical constitution and allergenic potential of red propolis extract (RPE). They were evaluated, using high performance liquid chromatography (HPLC) and the release of β-hexosaminidase, respectively. A plethora of biologically active polyphenols and the absence of allergic responses were evinced. RPE inhibited the release of β-hexosaminidase, suggesting that the extract does not stimulate allergic responses. Additionally, the physicochemical properties and antibacterial activity of hydrogel membranes loaded with RPE were analyzed. Bio-polymeric hydrogel membranes (M) were obtained using 5% carboxymethylcellulose (M1 and M2), 1.0% of citric acid (M3) and 10% RPE (for all). Their characterization was performed using thermal analysis, Fourier transform infrared (FTIR), total phenolic content, phenol release test and, antioxidant activity through 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and Ferric Reducing Antioxidant Power (FRAP). The latter appointed to the similar antioxidant capacity of the M1, M2 and M3. The degradation profiles showed higher thermostability to M3, followed by M2 and M1. The incorporation of RPE into the matrices and the crosslinking of M3 were evinced by FTIR. There were differences in the release of phenolic compounds, with a higher release related to M1 and lower in the strongly crosslinked M3. The degradation profiles showed higher thermostability to M3, followed by M2 and M1. The antibacterial activity of the membranes was determined using the disc diffusion assay, in comparison with controls, obtained in the same way, without RPE. The membranes elicited antibacterial activity against

Indexed as

Administration, TopicalAllergensAnimalsAnti-Bacterial AgentsAntioxidantsBandagesbeta-N-AcetylhexosaminidasesBiocompatible MaterialsBiopolymersBrazilCell LineChemical PhenomenaChromatography, High Pressure LiquidDrug CompoundingDrug StabilityHumansAllergensAnti-Bacterial AgentsAntioxidantsbeta-N-AcetylhexosaminidasesBiocompatible MaterialsBiopolymersHydrogelsMembranes, ArtificialPhenolsPropolisallergenic activityanti-staphylococcalbiopolymerchromatographic profilephytochemical screeningsodium carboxymethylcellulose

Identifiers

PMID33317120
PMCPMC7763695
OpenAlexW3110690056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.